Metabolic Activity Dead Cell Apoptosis Kit with C12 Resazurin, Annexin V APC, and SYTOX™ Green, for flow cytometry
Metabolic Activity Dead Cell Apoptosis Kit with C12 Resazurin, Annexin V APC, and SYTOX™ Green, for flow cytometry
Invitrogen™

Metabolic Activity Dead Cell Apoptosis Kit with C12 Resazurin, Annexin V APC, and SYTOX™ Green, for flow cytometry

このフローサイトメトリー製品は、生細胞、アポトーシスを起こしている細胞、後期アポトーシスを起こしている細胞を区別する3色蛍光アッセイを提供します。これらの集団は、633 nmと488 nmの励起源(アルゴンイオンレーザーとHeNeレーザー)の両方を備えたフローサイトメーター詳細を見る
製品番号(カタログ番号)数量
V351141 kit
製品番号(カタログ番号) V35114
価格(JPY)
209,900
1 kit
お問い合わせください ›
数量:
1 kit
このフローサイトメトリー製品は、生細胞、アポトーシスを起こしている細胞、後期アポトーシスを起こしている細胞を区別する3色蛍光アッセイを提供します。これらの集団は、633 nmと488 nmの励起源(アルゴンイオンレーザーとHeNeレーザー)の両方を備えたフローサイトメーター、ホスファチジルセリン、細胞代謝用C12レザズリン、および損なわれた膜用のSYTOX™ Green核酸染色を検出するための以下の試薬アネキシンVを使用して簡単に識別できます。

フローサイトメトリー用のすべてのアポトーシスアッセイの選択ガイドを参照してください。
研究用にのみ使用できます。診断用には使用いただけません。
仕様
励起/発光C12-レザズリン:571⁄585、SYTOX™ green:503⁄524、APC:650⁄660
フローサイトメーターレーザーライン633/635、488
使用対象(アプリケーション)フローサイトメトリー
使用対象 (装置)蛍光顕微鏡、フローサイトメーター
反応数50 reactions
製品ラインSYTOX
製品タイプDead Cell Apoptosis Kit
数量1 kit
出荷条件湿氷
コンジュゲートAPC、SYTOX™ Green、C12-レザズリン
フォーマットチューブ、スライド
Unit Size1 kit
組成および保存条件
1バイアルのアネキシンV、APCコンジュゲート(250 µL)、1バイアルのSYTOX™ green染色剤(100 µL)、1バイアルのC12-レザズリン(40 µg)、および1バイアルのDMSO(1.5 mL)を含みます。

冷蔵庫(2~8℃)に保存し、遮光。

よくあるご質問(FAQ)

How do SYTO dyes bind to DNA?

The binding mode of SYTO nucleic acid stains is unknown. However, the behavior of these and related nucleic acid dyes suggests the following binding properties:

1.They appear to contact the solvent (suggested by sensitivity to salt, divalent cations, and in particular, SDS) and thus are likely to have contacts in the grooves.
2.All SYTO dyes appear to show some base selectivity and are thus likely to have minor groove contacts.
3.They can be removed from nucleic acid via ethanol precipitation; this characteristic is not shared by ethidium bromide and other intercalators. Likewise, the dyes are not removed from nucleic acid via butanol or chloroform extraction. These extraction methods do remove ethidium bromide from nucleic acid. 4. SYTO binding is not affected by nonionic detergents.
5. SYTO dyes are not quenched by BrdU, so they do not bind nucleic acids in precisely the same way as Hoechst 33342 and DAPI ((4′,6-diamidino-2-phenylindole).

SYBR Green I has shown little mutagenicity on frameshift indicator strains, indicating that it isn't likely to strongly intercalate.

Find additional tips, troubleshooting help, and resources within our Cell Analysis Support Center.

I trypsinized my adherent cells and labeled with annexin V, and now my flow data is showing a high percentage of apoptotic cells even for control, untreated cells. What is the problem?

Trypsinization or mechanical scraping of cells temporarily disrupts the plasma membrane, allowing annexin V to bind phosphatidylserine on the cytoplasmic surface of the cell membrane and thus leading to false positive staining. Allow the cells to recover for about 30 minutes in optimal cell culture conditions and medium after trypsinizing/scraping so that they can recover their membrane integrity before staining. For lightly adherent cell lines, such as HeLa and NIH 3T3, another option is to use non-enzyme treatments like Gibco Cell Dissociation Buffer (Cat. No. 13151014).

Find additional tips, troubleshooting help, and resources within our Cell Analysis Support Center.

Can I detect annexin V staining in an imaging assay?

Annexin V staining is not typically used in imaging experiments; it is a better reagent for flow cytometry analysis. All cells will stain to some extent, so it can be difficult to distinguish a relatively bright annexin V-stained cell from a dimmer non-apoptotic cell. Caspase activation, detected using our CellEvent Caspase 3/7 or Image-iT LIVE Caspase detection kits, is a better method for detecting apoptosis in an imaging assay.

Find additional tips, troubleshooting help, and resources within our Cell Analysis Support Center.

When should I stain adherent cells with annexin V for flow cytometric analysis? Before or after I trypsinize them?

Trypsinize first and then allow the cells to recover about 30 minutes in optimal cell culture conditions and medium before staining with annexin V conjugates. Trypsinization or mechanical scraping of cells temporarily disrupts the plasma membrane, allowing for annexin V to bind phosphatidylserine on the cytoplasmic surface of the cell membrane and thus leading to false positive staining. For lightly adherent cell lines such as HeLa and NIH 3T3, you could use a less harsh (non-enzymatic) dissociation product like Gibco Cell Dissociation Buffer (Cat. No. 13151014).

Find additional tips, troubleshooting help, and resources within our Cell Analysis Support Center.

Can I fix my cells after annexin V labeling?

Annexin V staining is best analyzed on live cells. If you need to fix your cells for analysis, then fix in 3.7% formaldehyde in PBS containing calcium and magnesium to maintain binding during fixation. The signal will not be retained after permeabilization, thus annexin V staining is not compatible with internal antibody labeling.

Find additional tips, troubleshooting help, and resources within our Cell Analysis Support Center.

引用および参考文献 (2)

引用および参考文献
Abstract
Bruton's tyrosine kinase is at the crossroads of metabolic adaptation in primary malignant human lymphocytes.
Authors:Sharif-Askari B, Doyon D, Paliouras M, Aloyz R
Journal:Sci Rep
PubMed ID:31363127
'In this work we explored metabolic aspects of human primary leukemic lymphocytes that hold a potential impact on the treatment of Bruton tyrosine kinase (BTK)-driven diseases. Our results suggest that there is crosstalk between Bruton tyrosine kinase (BTK) signaling and bioenergetic stress responses. In primary chronic lymphocytic leukemia (CLL) lymphocytes, ... More
Ibrutinib Resistance Is Reduced by an Inhibitor of Fatty Acid Oxidation in Primary CLL Lymphocytes.
Authors:Galicia-Vázquez G, Aloyz R
Journal:Front Oncol
PubMed ID:30319974
Chronic Lymphocytic Leukemia (CLL) is an incurable disease, characterized by the accumulation of malignant B-lymphocytes in the blood stream (quiescent state) and homing tissues (where they can proliferate). In CLL, the targeting of B-cell receptor signaling through a Burton's tyrosine kinase inhibitor (ibrutinib) has rendered outstanding clinical results. However, complete ... More